The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
Open accessAbstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer syndrome, characterized primarily by multiple tumors in the parathyroid glands, endocrine pancreas, and anterior pituitary. Other tumors, including gastrinoma, carcinoid, adrenal cortical tumors, angiofibroma, collagenoma, and lipoma, also occur in some patients. Individuals with MEN1 almost always have loss-of-function mutations in the MEN1 gene on chromosome 11, and endocrine tumors arising in these patients usually show somatic loss of the remaining wild-type allele. To examine the role of MEN1 in tumor formation, a mouse model was generated through homologous recombination of the mouse homolog Men1 . Homozygous mice die in utero at embryonic days 11.5–12.5, whereas heterozygous mice develop features remarkably similar to those of the human disorder. As early as 9 months, pancreatic islets show a range of lesions from hyperplasia to insulin-producing islet cell tumors, and parathyroid adenomas are also frequently observed. Larger, more numerous tumors involving pancreatic islets, parathyroids, thyroid, adrenal cortex, and pituitary are seen by 16 months. All of the tumors tested to date show loss of the wild-type Men1 allele, further supporting its role as a tumor suppressor gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,534
Self-citationPositional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Self-citationWT-1 is required for early kidney development
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90515-r · Cited by 1,989
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
Requirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., & te Rielef, H. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,008
Laser Capture Microdissection: Molecular Analysis of Tissue
Bonner, R. F., Emmert-Buck, M., Cole, K., Pohida, T., Chuaqui, R., Goldstein, S., & Liotta, L. A. (1997) · Science · doi:10.1126/science.278.5342.1481 · Cited by 874
Self-citationTumour predisposition in mice heterozygous for a targeted mutation in Nf1
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 778
Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 667
Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription
Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80967-8 · Cited by 627
Self-citationA subset of p53-deficient embryos exhibit exencephaly
Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., & Jacks, T. (1995) · Nature Genetics · doi:10.1038/ng0695-175 · Cited by 580
Ludwig, T., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1997) · Genes & Development · doi:10.1101/gad.11.10.1226 · Cited by 539
Agarwal, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1169 · Cited by 477
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Trump, D., Farren, B., Wooding, C., Pang, J. T., Besser, G. M., Buchanan, K. D., Edwards, C. R., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · doi:10.1093/qjmed/89.9.653 · Cited by 471
High-frequency developmental abnormalities in p53-deficient mice
Armstrong, J. F., Kaufman, M. H., Harrison, D. J., & Clarke, A. R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00183-7 · Cited by 467
Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1
Bassett, J. H. D., Forbes, S. A., Pannett, A. A. J., Lloyd, S. E., Christie, P. T., Wooding, C., Harding, B., Besser, G. M., Edwards, C. R., Monson, J. P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301729 · Cited by 444
Menin, the product of the MEN1 gene, is a nuclear protein
Guru, S. C., Goldsmith, P. K., Burns, A. L., Marx, S. J., Spiegel, A. M., Collins, F. S., & Chandrasekharappa, S. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1630 · Cited by 434
Self-citationSomatic mutation of the MEN1 gene in parathyroid tumours
Heppner, C., Kester, M. B., Agarwal, S. K., Debelenko, L. V., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Olufemi, S.-E., Skarulis, M. C., Doppman, J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-375 · Cited by 415
Self-citationThe Genetic Basis of Human Cancer
Rubin, C. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00045 · Cited by 411
Loss of Apc+ in intestinal adenomas from Min mice.
Luongo, C., Moser, A. R., Gledhill, S., & Dove, W. F. (1994) · PubMed · Cited by 369
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
Gnarra, J. R., Ward, J. M., Porter, F. D., Wagner, J. R., Devor, D. E., Grinberg, A., Emmert-Buck, M. R., Westphal, H., Klausner, R. D., & Linehan, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9102 · Cited by 362
Self-citationMultiple endocrine neoplasia type 1.
Pannett, A. A., & Thakker, R. V. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060449 · Cited by 345
Clonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1
Friedman, E., Sakaguchi, K., Bale, A. E., Falchetti, A., Streeten, E., Zimering, M. B., Weinstein, L. S., McBride, W. O., Nakamura, Y., Brandi, M.-L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907273210402 · Cited by 334
Self-citationFranklin, D. S., Godfrey, V. L., O'Brien, D. A., Deng, C., & Xiong, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6147-6158.2000 · Cited by 297
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T. A., Wang, C., Park, W. S., Agarwal, S. K., Debelenko, L., Kester, M. B., et al. (1997) · PubMed · Cited by 294
Self-citationDonehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D., & Varmus, H. E. (1995) · Genes & Development · doi:10.1101/gad.9.7.882 · Cited by 276
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
Debelenko, L. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2285 · Cited by 257
Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang, Z., Ezzat, S., Vortmeyer, A. O., Weil, R. J., Oldfield, E. H., Park, W. S., Pack, S., Huang, S. C., Agarwal, S. K., Guru, S. C., et al. (1997) · PubMed · Cited by 246
Self-citationClinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1
Skogseid, B. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.76 · Cited by 234
McClatchey, A. I., Saotome, I., Ramesh, V, Gusella, J. F., & Jacks, T. (1997) · Genes & Development · doi:10.1101/gad.11.10.1253 · Cited by 207
Moser, A. R., Shoemaker, A. R., Connelly, C. S., Clipson, L., Gould, K. A., Luongo, C., Dove, W. F., Siggers, P. H., & Gardner, R. L. (1995) · Developmental Dynamics · doi:10.1002/aja.1002030405 · Cited by 163
Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia Type I
Benson, L., Ljunghall, S., Åkerström, G., & Öberg, K. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90008-8 · Cited by 141
Multiple Endocrine Neoplasia Type I
Marx, S. J., Vinik, A. I., Santen, R. J., Floyd, J. C., Mills, J. L., & Green, J. (1986) · Medicine · doi:10.1097/00005792-198607000-00003 · Cited by 105
Self-citationPoncin, J., Abs, R., Velkeniers, B., Bonduelle, M., Abramowicz, M. J., Legros, J., Verloès, A., Meurisse, M., Gaal, L. V., Verellen, C., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:1<54::aid-humu6>3.0.co;2-k · Cited by 94
Guru, S. C., Crabtree, J. S., Brown, K. D., Dunn, K. J., Manickam, P., Prasad, N. B., Wangsa, D., Burns, A. L., Spiegel, A. M., Marx, S. J., et al. (1999) · Mammalian Genome · doi:10.1007/s003359901051 · Cited by 78
Self-citationFrost, A. R., Sparks, D., & Grizzle, W. E. (2000) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200009000-00011 · Cited by 68
Nf1gene targeting: toward models and mechanisms
Cichowski, K. M., Shih, T. S., & Jacks, T. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0037 · Cited by 11
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Yokoyama, A., Somervaille, T. C. P., Smith, K. S., Rozenblatt-Rosen, O., Meyerson, M., & Cleary, M. L. (2005) · Cell · doi:10.1016/j.cell.2005.09.025 · Cited by 688
Lemos, M. C., & Thakker, R. V. (2008) · Human Mutation · doi:10.1002/humu.20605 · Cited by 675
Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus
Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C. A., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00081-4 · Cited by 645
Metadata
- Authors
- Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., Spiegel, A. M., & Collins, F. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-01-30
- Volume
- 98
- Issue
- 3
- Pages
- 1118-1123
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2111301538
- Cited by
- 472
- References
- 41
- FWCI
- 18.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.